search
  • Country
    Clear
  • Type
  • Compatibility Level
  • Thematic
  • Jurisdiction
1,903 Data sources

  • NL
  • SG
  • DK

  • DANS Data Station Physical and Technical Sciences

    more_vert
  • more_vert
  • more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • more_vert
  • This site provides access to the research output of the business school. The interface is in Danish and English and contains RSS feeds to alert users to new content. Some items are not available as full-text.

    more_vert
  • more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right
1,903 Data sources
  • DANS Data Station Physical and Technical Sciences

    more_vert
  • more_vert
  • more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • more_vert
  • This site provides access to the research output of the business school. The interface is in Danish and English and contains RSS feeds to alert users to new content. Some items are not available as full-text.

    more_vert
  • more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right